Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
10 Nonetheless, any new diabetes drug must still demonstrate safety concerning cardiovascular outcomes, and many new agents continue to undergo cardiovascular outcomes trials to meet these standards
To complement direct checkpoint blockade, an equally fundamental strategy for counteracting adaptive resistance involves broadening the repertoire and increasing the frequency of tumor-specific T cells using DC-based vaccines
Preclinical findings derived from cellular and animal models are distinguished from translational observations and human data, including pilot studies, observational cohorts, and randomized clinical trials
Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy (DURATION-8): A 28 Week, Multicentre, Double-Blind, Phase 3, Randomised Control
US$ 27.83
US$ 23.63
US$ 22.85
US$ 29.19
US$ 26.19
